IsoRay, Inc. to Present at the 2nd Annual Disruptive Growth & Healthcare Conference

NEW YORK, NY / ACCESSWIRE / February 2, 2017 / IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck, and gynecological cancers, announced today that it will be presenting at the 2nd annual Disruptive Growth & Healthcare Conference on Wednesday, February 15, 2017 at 12:45 PM EST. Tom LaVoy, Chairman and CEO, will be presenting, as well as meeting with investors.

The 2017 Disruptive Growth & Healthcare Conference will offer the exclusive opportunity to discover life science companies focusing on solutions to unmet medical needs and growth companies with disruptive technologies and business models.

A webcast of the presentation will be available here: http://www.investorcalendar.com/event/11178

News Compliments of Accesswire.

About IsoRay, Inc.

IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body. Learn more about this innovative Richland, Washington Company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com. Join us on Facebook/IsoRay. Follow us on Twitter @IsoRay.

About Source Capital Group, Inc.

The Investment Banking Group at Source Capital offers a wealth of Wall Street experience to the underserved small cap company sector through its seasoned professionals. They have successfully funded both public and private companies with an emphasis on Structured Credit and unique equity capital markets transactions, creating tailor-made solutions to enhance their clients’ balance sheets. Source Capital Group began as an independent firm specializing in small to medium-sized investment banking transactions. Since 1992, it has grown into a full-service financial institution, while adhering to the highest standards of quality and integrity.

For those interested in attending, please contact Richard Kreger at rkreger@sourcegrp.com or visit www.DisruptNYC.com for more information.

Contact:

Stephanie Prince, Managing Director
PCG Advisory Group
sprince@pcgadvisory.com
(646) 762-4518

SOURCE: IsoRay, Inc.

ReleaseID: 454070